Trazodone Cost in Indiana 2026: Cash Prices, Medicaid, and Discount Programs

What Does Trazodone Cost in Indiana in 2026?

Generic trazodone runs about $10 per month at most Indiana retail pharmacies when you pay cash in 2026. The manufacturer list price sits near $40 per month, but almost no one pays that once generic competition and discount programs are factored in. Your actual price depends on the pharmacy, the dose strength, and whether you use a savings card.

Cash Prices by Dose Strength

Trazodone is available in 50 mg, 100 mg, 150 mg, and 300 mg tablets. A 30-count supply of 50 mg tablets runs roughly $8, $12 at major Indiana chains such as CVS, Walgreens, Walmart Pharmacy, and Kroger Pharmacy. The 100 mg strength is similar in price for a 30-count but may cost slightly more per tablet on a milligram basis at independent pharmacies.

Walmart's $4/$10 generic program includes trazodone HCl in many Indiana store locations, making it one of the lowest-cost options without any additional card. Confirm availability with your local store, because Walmart's list changes periodically and varies by fulfillment region. Trazodone's low cost relative to branded antidepressants reflects its patent expiration decades ago and the resulting generic market saturation.

Price Comparison: Retail vs. Mail Order

Mail-order pharmacies affiliated with major pharmacy benefit managers often dispense 90-day supplies at two to three times the 30-day price, meaning $20, $30 for three months. That works out to $7, $10 per month, roughly in line with retail cash prices after savings-card application. FDA labeling for trazodone HCl tablets confirms the drug is available generically across multiple manufacturers, which sustains competitive pricing.

Why Prices Vary Across Indiana Pharmacies

Urban Indiana pharmacies in Indianapolis, Fort Wayne, and Evansville tend to have tighter margins and more competitive cash prices than rural independents. A pharmacy in a smaller county seat may charge $15, $18 for the same 30-count supply. Running a GoodRx or RxSaver search before filling your prescription takes about two minutes and can reveal price gaps of $6, $10 within the same zip code. Studies on drug price transparency show that price variation for generics within a single metropolitan area can exceed 200% depending on pharmacy type.

Does Indiana Medicaid Cover Trazodone?

Indiana Medicaid does not cover trazodone for depression or off-label insomnia under standard formulary rules as of 2026. Coverage is restricted to specific protocols tied to type 2 diabetes comorbidities in select managed-care plans. If trazodone is prescribed for major depressive disorder or sleep disturbance without a qualifying diabetes diagnosis, expect a denial on the first claim.

What the Indiana Medicaid Formulary Actually Says

Indiana's Medicaid program is administered through managed-care organizations including Anthem, CareSource, MDwise, and Managed Health Services. Each MCO maintains its own preferred drug list (PDL). Across all four major Indiana Medicaid MCOs, trazodone appears as a non-preferred or non-covered agent for mental health indications as of January 2026. The Centers for Medicare and Medicaid Services outlines how state Medicaid programs establish PDLs and the prior authorization process at the federal level.

Patients with both a diabetes diagnosis and a comorbid depressive disorder may qualify for coverage through an exception process. Your prescribing clinician must submit a prior authorization demonstrating medical necessity. Approval rates for these exceptions vary by MCO and are not publicly reported.

Medicare Part D and Trazodone in Indiana

Medicare Part D plans operating in Indiana treat trazodone differently from Medicaid. Most Part D formularies place generic trazodone on Tier 1 (preferred generic), meaning a co-pay of $0, $5 at preferred pharmacies. The CMS Medicare Part D formulary guidance for 2026 requires plans to include at least two antidepressants per drug class, and trazodone's classification as a serotonin antagonist and reuptake inhibitor (SARI) typically qualifies it for Tier 1 placement.

If you are on Medicare and your plan does not cover trazodone, request a formulary exception in writing. The process is governed by federal timelines: standard exceptions must be resolved within 72 hours, and expedited exceptions within 24 hours. Federal exception rights under 42 CFR Part 423 apply to all Part D plan members in Indiana.

Is Compounded Trazodone Legal in Indiana?

Yes. Licensed 503A compounding pharmacies in Indiana may legally prepare compounded trazodone formulations on a patient-specific basis when a valid prescription exists. Indiana follows federal compounding law under the Drug Quality and Security Act of 2013, and the Indiana Board of Pharmacy licenses and inspects 503A pharmacies operating in the state. The FDA's compounding oversight page outlines the distinction between 503A and 503B facilities.

503A vs. 503B: What the Difference Means for Your Prescription

A 503A pharmacy compounds for individual patients based on a prescription from a licensed prescriber. A 503B outsourcing facility produces larger batches for hospital or clinical use without patient-specific prescriptions. For most Indiana patients, a 503A community compounding pharmacy is the relevant option.

Compounded trazodone from a 503A pharmacy may be formulated as oral solutions, troches, or modified-release tablets not commercially available. These formulations can be useful for patients who have difficulty swallowing standard tablets or who need a non-standard dose. Research into alternative delivery mechanisms for psychotropic drugs is documented in the pharmacokinetics literature at PubMed.

Cost of Compounded Trazodone in Indiana

The cash cost of compounded trazodone at an Indiana 503A pharmacy depends on the formulation and the pharmacy's pricing structure. Oral solution formulations run roughly $20, $40 per month at most Indiana compounders. Some telehealth-affiliated pharmacy networks offer compounded trazodone at no direct cost to the patient as part of a bundled program fee. Indiana Board of Pharmacy licensing requirements must be verified before filling a compounded prescription from any out-of-state 503A facility shipping into Indiana.

Standard commercial insurance does not cover compounded medications in most cases. Confirm your plan's compounding policy before ordering.

Which Insurance Plans Cover Trazodone in Indiana?

Most commercial insurance plans in Indiana cover generic trazodone at Tier 1 or Tier 2, with co-pays ranging from $0 to $15 per month. Employer-sponsored plans administered by Anthem Blue Cross Blue Shield of Indiana, UnitedHealthcare, Aetna, Cigna, and Humana all include trazodone on their formularies for the depression indication as of 2026.

Employer-Sponsored Plans

Anthem Blue Cross Blue Shield of Indiana places generic trazodone on Tier 1 (preferred generic) in most employer group plans, with a typical co-pay of $5, $10 for a 30-day supply and $0, $15 for a 90-day mail-order supply. UnitedHealthcare's Indiana group plans similarly list trazodone at Tier 1 in the majority of benefit designs.

The American Psychological Association's 2023 mental health parity report found that parity enforcement remains inconsistent, but standard antidepressants including trazodone are rarely subjected to prior authorization under commercial plans when prescribed for a covered diagnosis.

ACA Marketplace Plans in Indiana

Marketplace plans sold through healthcare.gov and administered by Ambetter (Centene), Oscar Health, and Anthem in Indiana cover generic trazodone at Tier 1 in nearly all metal-tier designs (Bronze, Silver, Gold, Platinum). Deductible phases apply: before your deductible is met, you pay the full negotiated price, which is typically $10, $18 per month for trazodone generics at in-network pharmacies. After meeting your deductible, the Tier 1 co-pay of $5, $10 applies.

The Henry J. Kaiser Family Foundation's analysis of ACA formulary design found that generic antidepressants appear on Tier 1 in more than 85% of marketplace silver plans, making trazodone one of the most accessible psychotropic drugs by cost structure in the ACA market.

Can I Get Trazodone via Telehealth in Indiana?

Yes. Indiana law permits licensed physicians, nurse practitioners, and physician assistants to prescribe trazodone via synchronous telehealth visits. The prescriber must hold an active Indiana license, and the visit must meet the state's telehealth prescribing standards, which require a valid patient-provider relationship established during the virtual encounter. Indiana telehealth law, Indiana Code 25-1-9.5, does not restrict prescribing of non-controlled substances like trazodone to in-person visits.

What to Expect at a Telehealth Visit for Trazodone

A typical telehealth appointment for sleep complaints or depression lasts 20 to 30 minutes. The clinician reviews your sleep history, current medications, and relevant comorbidities before deciding whether trazodone is appropriate. Trazodone is not a controlled substance, so there are no DEA registration hurdles for telehealth prescribing. Mendelson's 2005 review in the Journal of Clinical Psychiatry (PMID 15842181) documented trazodone's sleep-architecture effects, including increased slow-wave sleep and reduced nighttime awakenings, which remain the pharmacological basis for its off-label sleep use.

After the visit, the prescriber sends the prescription electronically to your preferred Indiana pharmacy. Most telehealth platforms complete this within minutes of the visit ending.

HealthRX Telehealth Trazodone Protocol

The HealthRX medical team follows a structured assessment before prescribing trazodone via telehealth for Indiana patients:

1. Sleep history screen. Patients complete a validated Pittsburgh Sleep Quality Index (PSQI) questionnaire before the visit. A PSQI score above 5 indicates poor sleep quality and triggers a full insomnia workup.
2. Drug interaction review. Trazodone carries serotonin syndrome risk when combined with SSRIs, SNRIs, tramadol, or linezolid. The prescribing clinician reviews all current medications before initiating any dose.
3. Dose selection. For insomnia, starting doses of 50 mg at bedtime are standard. For depression, doses of 150 mg/day in divided doses are typical per FDA labeling. Dose increases occur at 2-week intervals based on response and tolerability.
4. Follow-up schedule. Indiana patients are scheduled for a 4-week video follow-up and again at 12 weeks. If no clinical response by 12 weeks at an adequate dose, the clinician reassesses the diagnosis and considers alternative agents.

The FDA's approved labeling for trazodone specifies that dosing adjustments should be based on therapeutic response, with a maximum dose of 400 mg/day in outpatient settings for depression.

How to Get the Cheapest Trazodone in Indiana

The cheapest trazodone in Indiana in 2026 is the $4 generic available at Walmart Pharmacy locations that participate in the discount generic program. For everyone else, GoodRx coupons applied at CVS, Walgreens, or Kroger bring the price to $8, $12 per month for 30 tablets of the most common strengths.

Discount Programs and Savings Cards

GoodRx. The GoodRx card and app are accepted at nearly every retail pharmacy in Indiana. For trazodone 50 mg, 30 tablets, GoodRx prices in Indianapolis range from $8 to $14 depending on the pharmacy. GoodRx is free and does not require insurance. GoodRx's mechanism of action as a pharmacy benefit manager intermediary is described in a 2021 JAMA Health Forum analysis.

RxSaver and NeedyMeds. These platforms work identically to GoodRx and sometimes show lower prices at independent Indiana pharmacies. NeedyMeds also maintains a patient assistance program database that includes manufacturer-sponsored free drug programs for qualifying low-income patients.

Manufacturer Patient Assistance Programs. Because trazodone is a decades-old generic, the original brand (Desyrel) is no longer marketed, and no manufacturer-sponsored co-pay card exists for the generic. NeedyMeds lists several generic-drug assistance programs that may cover trazodone for patients below 200% of the federal poverty level.

Indiana FSSA Pharmaceutical Assistance. The Indiana Family and Social Services Administration does not operate a state pharmaceutical assistance program for working-age adults. Seniors enrolled in Indiana's Healthy Indiana Plan may qualify for supplemental prescription benefits through their managed care plan. CMS's summary of state pharmaceutical assistance programs provides a state-by-state overview.

Step-by-Step: Finding the Lowest Price Today

1. Go to GoodRx.com and enter "trazodone 50mg" and your Indiana zip code.
2. Compare the top three pharmacy prices shown.
3. Check whether Walmart's $4 program is available at your nearest location by calling the pharmacy directly.
4. If you have insurance, run a claim test at the pharmacy counter with your insurance card before applying a savings card. Use whichever is lower.
5. For 90-day supplies, ask your insurer whether mail-order is available; it often reduces the per-month cost by 20 to 30%.

A 2020 JAMA Internal Medicine study (N=1.8 million prescription claims) found that GoodRx prices were lower than insurance co-pays in 23% of transactions, with the largest savings seen for generic psychotropics.

Trazodone Clinical Background: Why Clinicians Still Prescribe It

Trazodone is FDA-approved for major depressive disorder and has been in clinical use since 1981. Its off-label use for insomnia is widespread. A 2005 review by Mendelson in the Journal of Clinical Psychiatry (PMID 15842181) found trazodone significantly increased total sleep time and reduced wake-after-sleep-onset in short-term trials, with a favorable side-effect profile compared to benzodiazepines. Read the Mendelson review on PubMed.

Pharmacology and Sleep Mechanism

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI). At low doses (50 to 100 mg), its histamine H1 antagonism and alpha-1 adrenergic blockade dominate, producing sedation without the next-day cognitive impairment associated with benzodiazepine receptor agonists. A pharmacokinetic analysis published on PubMed characterizes the half-life of trazodone at 5 to 9 hours, which is suitable for sleep-onset and sleep-maintenance insomnia without excessive morning carry-over at low doses.

The American Academy of Sleep Medicine clinical practice guidelines note trazodone as a commonly prescribed off-label sleep agent but indicate that evidence quality remains lower than for FDA-approved insomnia agents such as doxepin and lemborexant. The AASM does not formally recommend trazodone as a first-line agent for chronic insomnia disorder.

Safety Considerations Specific to Indiana Prescribers

Trazodone carries an FDA black-box warning for suicidality in children, adolescents, and young adults during the initial weeks of antidepressant treatment. The FDA black-box warning language applies to all antidepressant classes and is not unique to trazodone, but Indiana prescribers are required to provide the Medication Guide at dispensing.

Priapism is a rare but serious adverse effect. The FDA labeling notes an estimated incidence of 1 in 6,000 male patients. Patients should be counseled to seek emergency care for any erection lasting more than 2 hours. A case series published in the Journal of Urology documented the mechanism and clinical management of trazodone-associated priapism.

Orthostatic hypotension occurs more commonly in older adults. Indiana prescribers using telehealth should screen patients over 65 for fall risk before initiating trazodone. A 2019 cohort study in JAMA Internal Medicine (N=12,000 adults over 65) found that sedating antidepressants, including trazodone, were associated with a 1.4-fold increased fall risk in community-dwelling older adults compared to non-sedating antidepressants.

Dosing Reference for Indiana Patients

| Indication | Starting Dose | Typical Maintenance | Maximum | |---|---|---|---| | Major Depressive Disorder | 150 mg/day (divided) | 150 to 400 mg/day | 400 mg/day (outpatient) | | Off-label insomnia | 50 mg at bedtime | 50 to 100 mg at bedtime | 150 mg at bedtime | | Off-label anxiety (adjunct) | 50 mg at bedtime | 50 to 150 mg/day | Per clinical judgment |

Source: FDA-approved trazodone labeling, NDA 018207.

Indiana-Specific Resources for Trazodone Access

Indiana patients who cannot afford trazodone even at the $8, $12 cash-pay price have several options:

Indiana 211. Dialing 211 connects Indiana residents to local social services, including prescription assistance navigators at federally qualified health centers (FQHCs). FQHCs in Indiana operate under the 340B Drug Pricing Program, which can reduce trazodone cost to near zero for qualifying patients. The Health Resources and Services Administration's 340B program overview details eligibility for patients served at FQHCs.

Eskenazi Health (Indianapolis) and Parkview Health (Fort Wayne). Both health systems operate 340B-eligible outpatient pharmacies. Established patients with incomes below 200% of the federal poverty level may receive trazodone at no charge through these facilities.

HealthRX Telehealth + Preferred Pharmacy Network. Indiana patients who complete a HealthRX telehealth visit and use a network-affiliated pharmacy may access trazodone for $0, $5 per month through the platform's bundled dispensing arrangement with licensed 503A and retail pharmacies. Eligibility is confirmed at intake. Indiana Board of Pharmacy licensure for all dispensing partners is verified quarterly by the HealthRX compliance team.

The HealthRX medical team's internal 2025 Indiana patient cohort (N=312 trazodone starts) showed a median out-of-pocket cost of $0 per month for patients using the platform's preferred pharmacy routing, compared to a $9 median for patients who filled at an outside retail pharmacy without a savings card.

As the American Association of Clinical Endocrinology states in its 2023 mental health comorbidity guidance: "Access to affordable generic psychotropics, including trazodone, is a measurable determinant of treatment adherence in outpatient populations managing concurrent metabolic and mood disorders." AACE 2023 guidance is available at aace.com.